Diet and Nutrition Clinical Trials

A listing of Diet and Nutrition medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 442 clinical trials
featured
Multicultural Healthy Diet to Reduce Cognitive Decline

The Multicultural Healthy Diet (MHD) is a pilot randomized controlled clinical trial designed to test the effects of an 18-month intervention on cognitive function. MHD is an anti-inflammatory diet tailored to a multicultural population.

cognitive changes
nutrition education
nutritional assessment
diet modification
cognitive assessment
  • 0 views
  • 19 Feb, 2021
  • 1 location
featured
Translational characterization of blood pressure changes following the Dash Diet – from nutrition through electrolytes to exosomes

Uncontrolled hypertension is a significant cause of illness and death from stroke, heart diseases and kidney failure. These can be reduced by adhering to the DASH diet, which reduces sodium and increases potassium intake. The mechanism of this "DASH effect" is not known and we suspect specific proteins in the …

  • 0 views
  • 06 Apr, 2021
  • 1 location
featured
Diabetes, Type 2

A research study is now underway in the Miami area and is seeking participants with Type 2 Diabetes that are currently being treated with only metformin and/or diet and exercise.  

  • 56 views
  • 23 Nov, 2020
  • 1 location
HPV Vaccine Intervention for Young Sexual Minority Men

This phase III trial studies how well the Outsmart HPV intervention works in increasing HPV vaccine initiation and completion among young individuals who report having a history of same-sex partners, being sexually attracted to males, or identify as gay, bisexual, or queer (i.e., sexual minority males). The Outsmart HPV intervention, …

  • 0 views
  • 26 Jan, 2021
  • 2 locations
Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer

The main purpose of this study is to evaluate bintrafusp alfa monotherapy in participants with triple negative breast cancer (TNBC) who express high levels of HMGA2 as determined by a centralized reverse transcriptase-polymerase chain reaction (RT-PCR) test.

  • 0 views
  • 08 May, 2021
  • 46 locations
A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

The purpose of this study is to evaluate the efficacy and safety of camrelizumab (an engineered anti-programmed death-ligand 1 [PD-1] antibody) plus chemotherapy vs placebo plus chemotherapy as neoadjuvant therapy in participants with triple negative breast cancer (TNBC). Participants will be randomized in a 1:1 ratio to Arm A (camrelizumab …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

Phase III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple-negative Breast Cancer (TNBC)

formalin-fixed paraffin-embedded
breast cancer
measurable disease
mammogram
cancer
  • 1387 views
  • 21 Apr, 2021
  • 308 locations
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

The primary objective of this study is to demonstrate the non-inferiority of the vaccine seroresponse to meningococcal serogroups A, C, Y, and W following administration of 2 doses of MenACYW conjugate vaccine compared to 2 doses of MENVEO when given concomitantly with routine pediatric vaccines to infants and toddlers 6 …

  • 420 views
  • 14 Jun, 2021
  • 58 locations
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

Phase III, prospective, multi-center, randomized, open label, parallel group, study in patients with HER2-negative breast cancer with residual disease after neoadjuvant chemotherapy with 1:1 allocation to: Arm A: Sacituzumab govitecan (days 1, 8 q3w for eight cycles); Arm B: treatment of physicians choice (TPC, defined as capecitabine or platinum-based chemotherapy …

  • 0 views
  • 26 Jan, 2021
  • 32 locations
A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib Carelizumab Plus Nab-paclitaxel and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.

This randomized, open-label phase 3 study will evaluate the safety and efficacy of Carelizumab (an engineered anti-programmed death-ligand 1 [PD-1] antibody) in combination with Nab-paclitaxel and Apatinib, carelizumab plus nab-paclitaxel, and Nab-paclitaxel in Patients with Unresectable Locally Advanced or Metastatic Triple Negative Breast Cancer. Participants will be randomized in a …

locally advanced breast cancer
measurable disease
triple-negative breast cancer
erbb2
triple negative breast cancer
  • 0 views
  • 24 Jan, 2021
  • 1 location